Skip to main content

Ovarian cancer detection starts here

CLEO Diagnostics is making early diagnosis of ovarian cancer a reality with a simple and accurate blood test.

The technology is not yet commercially available and remains subject to further testing and regulatory approval. Please see the Prospectus under the “Prospectus” tab for further information.

 

ASX:COV

Share Price:  $

Movement:

Updated:

Currency: AUD

Share Price

$

Latest Announcements

Prospectus